GlassScriptPhysician profile
Emily R Blackmore
NPI 1659620490
$1,773.88
in general payments reported to CMS, 2019-2025
12 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $158 · 2023: $564 · 2024: $346 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211 · Education: $24.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.66 |
| Education | $24.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $407.17 | 2021-2024 | Farxiga |
| Novo Nordisk INC | $335.96 | 2021-2024 | Rybelsus, Ozempic |
| Corcept Therapeutics | $335.28 | 2023-2024 | Korlym |
| Sequel Med Tech, LLC | $163.29 | 2025 | Twiist |
| Lilly USA, LLC | $158.49 | 2022-2023 | Mounjaro |
| Abbott Laboratories | $156.96 | 2023-2025 | Freestyle Libre 3 |
| Cequr Corporation | $80.26 | 2024-2025 | Cequr Simplicity |
| Insulet Corporation | $46.84 | 2024 | Omnipod |
| Xeris Pharmaceuticals, INC. | $31.16 | 2023-2025 | Gvoke Hypopen |
| Dexcom, INC. | $21.46 | 2024 | Dexcom G6 Transmitter |
| Beta Bionics, INC. | $18.74 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Mannkind Corporation | $18.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Blackmore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.